307x Filetype PPTX File size 0.22 MB Source: sicsb.stemcell.conference.unair.ac.id
Introduction
•Clinical studies showed potential of Stem Cell based
therapy in the treatment of some degenerative,
autoimmune and genetic disorders.
•However, application of stem cell based therapy raises
some ethical and safety issues
•In Indonesia, many unproven “treatment” and direct-
to-customer marketing of different (non human) stem
cell interventions were offered in many ways
Ethical Challenges of h-ESC
•human embryonic stem cell (h-ESC) research has
a major ethical dilemma, since it may be started
with destruction of early human embryo.
•The pluripotency of h-ESC may generate many
different cell types, including teratomas and Risk
to get Parkinson
Volarevic et al. Int. J. Med. Sci. 2018, Vol. 15
Ethical Challenges of i-PSC
•Research and Clinical Application of Induced Pluripotent
Stem Cell (i-PSC) are considered morally better than h-ESC,
since it does not require destruction of human embryo
•Risk of potential exploitation of created embryo, and risk of
change natural reproduction including the possibility to
derive gametes for same-sex reproduction, as well as in the
asexual-reproduction
•Risk of transformation in to tumor cells
Volarevic et al. Int. J. Med. Sci. 2018, Vol. 15
Ethical Challenges of MSC
•Mesenchymal Stem Cell (MSC) can differentiate
into a variety of cell types of mesodermal origin
and neuro-ectodermal (neurons, astrocytes, and
oligodendrocytes) or endodermal (hepatocytes)
origin
•MSC may promote tumor growth and
metastasis, vision loss, detached retina
Volarevic et al. Int. J. Med. Sci. 2018, Vol. 15
Regulation in Indonesia
•The Law No 36 of 2009 regarding Health:
•Research and clinical application of Human Embryonic
Stem Cell (h-ESC) is not allowed
•Cell transplantation, either from human or animal
origin, may be applied only if its safety and benefits
were approved
•Stem Cell for reproduction of human being is forbidden
no reviews yet
Please Login to review.